Search research articles
Contact Us
Filters
Showing results (131-140 of 167) with videos related to
Page
of 17
Sort By:
Therapeutic Advances in Medical Oncology
|
May 17, 2021
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Tomi Jun, Umut Ozbek, Sirish Dharmapuri, et al.
Cancers
|
July 16, 2020
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade
David J Pinato, Takahiro Kaneko, Anwaar Saeed, et al.
Frontiers in Oncology
|
March 3, 2023
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
Y Linda Wu, Grace van Hyfte, Umut Özbek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies
Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, et al.
Journal for Immunotherapy of Cancer
|
September 2, 2020
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Petros Fessas, Ahmed Kaseb, Yinghong Wang, et al.
Journal for Immunotherapy of Cancer
|
October 8, 2020
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
David J Pinato, Ahmed Kaseb, Yinghong Wang, et al.
Nature Medicine
|
March 30, 2026
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Zev A Wainberg, Gulam A Manji, Nathan Bahary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, et al.
Hepatology Communications
|
April 28, 2022
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Rohini Sharma, Anjana Pillai, Thomas Urban Marron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor-Amplified Gastroesophageal Cancer: Retrospective Global Experience
Steven B Maron, Stephanie Moya, Federica Morano, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 167) with videos related to
Sort By:
Page
of 17
Therapeutic Advances in Medical Oncology
|
May 17, 2021
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Tomi Jun, Umut Ozbek, Sirish Dharmapuri, et al.
Cancers
|
July 16, 2020
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade
David J Pinato, Takahiro Kaneko, Anwaar Saeed, et al.
Frontiers in Oncology
|
March 3, 2023
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
Y Linda Wu, Grace van Hyfte, Umut Özbek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies
Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, et al.
Journal for Immunotherapy of Cancer
|
September 2, 2020
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Petros Fessas, Ahmed Kaseb, Yinghong Wang, et al.
Journal for Immunotherapy of Cancer
|
October 8, 2020
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
David J Pinato, Ahmed Kaseb, Yinghong Wang, et al.
Nature Medicine
|
March 30, 2026
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Zev A Wainberg, Gulam A Manji, Nathan Bahary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, et al.
Hepatology Communications
|
April 28, 2022
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Rohini Sharma, Anjana Pillai, Thomas Urban Marron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor-Amplified Gastroesophageal Cancer: Retrospective Global Experience
Steven B Maron, Stephanie Moya, Federica Morano, et al.
Page
of 17